Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice
- PMID: 15944824
- DOI: 10.1007/s10384-004-0187-3
Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice
Abstract
Purpose: To evaluate the efficacy of topical dexamethasone and topical FK506 treatment on allergic inflammation in conjunctiva, we performed a comparative study using a mouse experimental allergic conjunctivitis model.
Methods: The experimental allergic conjunctivitis model was developed by ovalbumin (OVA) instillation after OVA sensitization by intraperitoneal application of a mixed solution of OVA and aluminum hydroxide. The Balb/c mice of the experimental allergic conjunctivitis model were divided into three groups, depending on whether or not they received topical treatment and which type of treatment they received. The allergy group comprised six mice without topical treatment; the dexamethasone (Dx) group comprised six mice receiving topical 0.1% dexamethasone ointment treatment; and the FK506 (FK) group comprised six mice receiving topical 0.1% FK506 ointment treatment. The negative control group comprised six mice with neither sensitization nor topical treatment. For the histological examination, frozen sections of the eyelids, eyeballs, and lacrimal glands were stained with acid Giemsa stain or, in the immunohistochemical method, with alkaline phosphatase-antialkaline phosphatase (APAAP), for CD4. Densities of eosinophils and CD4-positive lymphocytes in the conjunctival tissue were counted. Productive C epsilon gene expression in the conjunctival tissue, including the lacrimal gland, was also evaluated by reverse transcriptase polymerase chain reaction (RT-PCR).
Results: In the histological study, the cell density of eosinophils infiltrating into subconjunctival tissues was 66.3 +/- 34.7 cells/mm(2) (mean +/- SD) for the allergy group, 2.5 +/- 4.2 cells/mm(2) for the Dx group, 4.2 +/- 8.6 cells/mm(2) for the FK group, and 3.7 +/- 7.6 cells/mm(2) for the negative control group. The cell density of CD4-positive cells infiltrating into subconjuctival tissues was 145.9 +/- 66.4 cells/mm(2) for the allergy group, 10.0 +/- 12.9 cells/mm(2) for the Dx group, 10.1 +/- 15.5 cells/mm(2) for the FK group, and 21.7 +/- 17.8 cells/mm(2) for the negative control group. The allergy group showed significant differences in the density of eosinophils and CD4-positive cells compared with those of the Dx (P < 0.0001) and FK (P < 0.0001) groups. In the RT-PCR study, the expression of productive C epsilon gene was positive in the Dx group, but negative in the allergy group, the FK group, and the negative control group.
Conclusions: Topical Dx and FK506 treatments were both efficacious in suppressing eosinophil and lymphocyte infiltration into subconjunctival tissue in the mouse experimental allergic conjunctivitis model. However, the influence of their IgE productive mechanisms seemed to differ, causing different efficacy of productive C epsilon gene expression in the conjunctival tissue.
Similar articles
-
Effects of dexamethasone on the expression of transforming growth factor-beta in the mouse model of allergic rhinitis.Laryngoscope. 2007 Aug;117(8):1323-8. doi: 10.1097/MLG.0b013e318064e84d. Laryngoscope. 2007. PMID: 17762268
-
The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis.Am J Rhinol Allergy. 2012 Mar-Apr;26(2):e71-5. doi: 10.2500/ajra.2012.26.3743. Am J Rhinol Allergy. 2012. PMID: 22487280
-
Histological study on mast cells in conjunctiva of NC/Nga mice.Jpn J Ophthalmol. 2004 May-Jun;48(3):189-94. doi: 10.1007/s10384-003-0048-5. Jpn J Ophthalmol. 2004. PMID: 15175908
-
Roles of T-cells in the development of allergic conjunctival diseases.Cornea. 2007 Oct;26(9 Suppl 1):S36-40. doi: 10.1097/ICO.0b013e31812f6970. Cornea. 2007. PMID: 17881914 Review.
-
Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.Cornea. 2011 Apr;30(4):462-5. doi: 10.1097/ICO.0b013e3181d83875. Cornea. 2011. PMID: 20861732 Review.
Cited by
-
Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model.J Pharm (Cairo). 2013;2013:680580. doi: 10.1155/2013/680580. Epub 2012 Nov 25. J Pharm (Cairo). 2013. PMID: 26555990 Free PMC article.
-
Conceptualization and Investigation of Multicomponent Polymer Networks as Prospective Corticosteroid Carriers.Gels. 2023 Jun 7;9(6):470. doi: 10.3390/gels9060470. Gels. 2023. PMID: 37367141 Free PMC article.
-
Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model.Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1717-21. doi: 10.1007/s00417-013-2333-4. Epub 2013 Apr 5. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23553288
-
Development of a Temperature and pH Dual-Sensitive In-Situ Gel for Treating Allergic Conjunctivitis.AAPS PharmSciTech. 2024 Sep 25;25(7):223. doi: 10.1208/s12249-024-02931-6. AAPS PharmSciTech. 2024. PMID: 39322789
-
Transconjunctival immunotherapy using cholera toxin B to treat experimental allergic conjunctivitis in a mouse model.Jpn J Ophthalmol. 2011 Sep;55(5):534-540. doi: 10.1007/s10384-011-0047-x. Epub 2011 Aug 9. Jpn J Ophthalmol. 2011. PMID: 21826470
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials